Global market valuation was derived through revenue mapping and procedure volume analysis across biodegradable and non-biodegradable categories. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa specializing in hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, PMMA microspheres, and polyalkylimide formulations
Product mapping across facial line correction, lip enhancement, nasolabial fold reduction, facial scar revision, and facelift augmentation segments
End-user analysis distinguishing hospital-based procedures (plastic surgery departments, reconstructive units) from specialty & dermatology clinic volumes (medical spas, standalone aesthetic centers)
Analysis of reported and modeled annual revenues specific to dermal filler portfolios, distinguishing biodegradable product lines (Juvederm, Restylane, Radiesse, Sculptra) from permanent fillers (Bellafill, Aquamid)
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (procedure volume × Average Selling Price by country, segmented by clinic type and product category) and top-down (manufacturer revenue validation across ISAPS-reported procedure statistics) approaches to derive segment-specific valuations for biodegradable versus non-biodegradable markets